1. Dr Pierre-Yves Norval WHO Stop TB Department
GFATM status for TB
Dr Pierre-Yves Norval
WHO Stop TB Department

2. GFATM support for TB (R1-5)
97 TB grants
73 countries
21/22 HBC
$ 819 M
approved
$ 295 M
disbursed
$ 150 M spent

3. Total NTP Budgets by Source of Funding
22 high-burden countries,
$ 836 M
+11%
$ 754 M
+9%
$ 690 M
+50%
16% tot.
67% grant
Total TB budget increased by 1/3 in 2004 (38%)
This increase is largely due Government increase which represent 2/3 of the budget
GFATM x2 in 2005 representing 66% of external source in 2005 but only 15% total budget
Other grant decreased in 2004 and 2005 but total grant continue to increase GFATM partially additional
$ 460 M
$ 413 M
+46%
+46%
57% tot.
Global TB Control Report: Surveillance, Planning, Financing. WHO Report 2005.

4. TB expenditure in 11 HBC (1/2 world pop, 1/3 TB case world) and impact on S+ CDR
+40%
$176 M
+28%
$137 M
Gov increase by 7% in and 20% in 2004 and represent more than 2/3 expenditure
Grant represent 1/3 half GFATM, half other
GFATM remain additional all other sources
GFATM increased by 91% between 2004 and 2003
Grant increased by 62% in 2003 and 21%in 2004
Loan increase 100%in 2004
Every 1% increased budget increase CDR by 0.5%
Success remain high
56%
+21%
47%
+12%
CDR S+
41%

5. Technical areas in alignment with Stop TB strategy and Global plan
DOTS expansion in all R1-5 including lab. support
TB/HIV in 64/105 TB and TB/HIV proposals (R1-5)
In 17/25 HIV proposals (R5)
MDR represents 75% of MDR projects worldwide
25,000 MDR TB cases (R1-5)
ACS in 9/24 (R5)
Community TB in 12/24 (R5)
PPM in 8/22 HBCs

6. TA for GFATM at global level
Proposal forms and guidelines
M&E systems
GLC : 2nd line TB drugs procurement and TA
Procurement: eligible 1st line drugs including GDF
Briefing TRP, portfolio managers
MOU Stop TB Partnership – GF on 19 May 2005
Coordinated TA from Stop TB Partners
Drug procurement via GDF and GLC

7. TA for GFATM at country level
Proposal preparation
TRP clarifications
Proposal to negotiation
M&E plan
PSM
Work plan
Grant implementation
Phase 2 preparation
TA provided
Qualitative
Quantitative
Coordinated TA